Jaguar Health 2025 Q2 Earnings Deepening Losses Amid Modest Revenue Growth

Jaguar Health reported its fiscal 2025 Q2 earnings on August 14, 2025. The company posted a modest 9.5% year-over-year revenue increase but recorded significantly wider losses, with no clear guidance provided. The results fell short of demonstrating meaningful progress toward profitability.

Jaguar Health reported total revenue of $2.98 million for the second quarter of 2025, a 9.5% increase from $2.72 million in the same quarter of 2024. Product revenue, the company's primary income source, accounted for $2.94 million of the total, with an additional $43,000 in license revenue contributing to the remaining portion.

Net losses widened significantly, with the company reporting a loss of $10.56 million for the quarter, up 9.7% from a $9.63 million loss in the prior year. On a per-share basis, the loss expanded to $10.26 from $2.66, marking a 285.7% increase in losses. The company has now posted losses for 11 consecutive years in the same quarter, underscoring ongoing financial challenges and a lack of profitability.

Despite the modest revenue growth, the earnings report was largely negative. The substantial increase in per-share losses highlights the company’s inability to control costs or generate sustainable profits. The financial performance indicates a deteriorating situation that remains far from stabilization, with no immediate signs of a turnaround.

Following the earnings report, Jaguar Health's stock price continued its downward trend. Over the latest trading day, the stock fell by 10.39%, while over the past week it declined by 1.43%. The month-to-date performance saw a sharper decline of 13.75%. The poor performance reflects investor skepticism and concerns about the company’s long-term viability.

The earnings report was followed by a notable underperforming investment strategy. A strategy of buying JAGX shares 30 days after a quarterly earnings report with a raised revenue forecast over the past three years resulted in a loss of -99.99%, underperforming the benchmark by 151.09%. The strategy exhibited a maximum drawdown of 0% and a Sharpe ratio of -0.57, indicating a high-risk approach with poor returns. The investment performance highlights the difficulty of identifying a profitable strategy given the company's financial instability.

Jaguar’s CEO emphasized the brand’s transformation into an electric-only luxury vehicle company, focusing on the new design philosophy of Exuberant Modernism. The launch of the Type 00 was highlighted as a key milestone, with the CEO expressing confidence in the brand's ability to stand out in a homogenous EV market through bold design and cutting-edge technology. The CEO also mentioned the upcoming launch of a four-door electric GT in late 2025, built on the Jaguar Electric Architecture (JEA), with a targeted driving range of up to 770 km (478 miles) WLTP or 430 miles (692 km) EPA, and a rapid charging capability of 321 km (200 miles) in as little as 15 minutes.

Jaguar did not provide explicit quantitative financial guidance during the earnings call. The company outlined forward-looking expectations, including the development of exclusive brand stores and immersive customer experiences to reflect the brand's renewed identity.

Additional News
In Nigeria, political and social developments dominated the news landscape in late August 2025. Sokoto State Governor Ahmed Aliyu announced a N2.5 billion grant for over 13,900 small-scale business owners under the second phase of the N-G CARES program. Meanwhile, Lagos State launched a child sexual abuse forensic interview protocol to improve investigations and prosecutions in such cases. The Nigerian government also evacuated 11 stranded miners from the Central African Republic and approved a N19.9 billion solar power rollout in Katsina State. Political parties intensified preparations for upcoming by-elections, while concerns over religious tolerance and human rights protection were raised in several states.